David C Atkinson

Title: Innovations by David C. Atkinson: Pioneering Treatments for Autoimmune and Inflammatory Diseases

Introduction

David C. Atkinson, an inventive mind based in Pembroke Pines, FL, has made significant strides in the field of medical treatments. With two patents to his name, he has focused his research on developing methods to combat arthritic and inflammatory diseases as well as autoimmune diseases. His innovative work leads to potential breakthroughs in therapeutic approaches.

Latest Patents

Atkinson's latest patents demonstrate his commitment to improving patient care. The first patent is a **Method of treatment for arthritic and inflammatory diseases**, which involves the daily administration of narcotic antagonists, namely nalmefene or naltrexone, in doses ranging from about 1 to about 100 mg. These medications may be administered orally in equally divided doses from one to four times daily or via a parenteral route when suitable.

The second patent, a **Method of treatment for autoimmune diseases**, similarly utilizes nalmefene or naltrexone, showcasing Atkinson's dedication to leveraging these narcotic antagonists in the treatment of diverse medical conditions.

Career Highlights

David C. Atkinson is currently affiliated with Baker Cummins Pharmaceuticals, Inc., where he applies his expertise in developing new therapeutic methods. His contributions are valuable in advancing the company's mission of providing innovative healthcare solutions.

Collaborations

Atkinson has worked alongside colleagues Fred P. Sherman and Jack Fishman, fostering a collaborative environment that encourages creativity and the sharing of ideas. This teamwork is essential in the pursuit of groundbreaking inventions and improvements in treatment methodologies.

Conclusion

David C. Atkinson’s innovative approach to treating autoimmune and inflammatory diseases establishes him as a noteworthy inventor in the medical field. With his patented methods, he contributes to the ongoing search for effective therapies, demonstrating the impact that dedicated inventors can have on healthcare advancements.